Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01096550 · ClinicalTrials.gov registry record · NA
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
A NA study of Drug Dependence, sponsored by Friends Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 319
- Enrollment target
- 1
- Study location
NCT01096550 is a NA study of Drug Dependence that has completed, run by Friends Research Institute. The registered enrollment target is 319 participants, above the 270-participant average among 9 other Drug Dependence trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01096550, a NA study of Drug Dependence, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 319 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of different levels of counseling (intensive outpatient versus standard outpatient) on treatment outcomes for African American adult patients receiving buprenorphine in 2 formerly "drug-free" programs.
Conditions Studied
Interventions
- BEHAVIORAL Outpatient
- BEHAVIORAL Intensive Outpatient
Study Locations (1)
Maryland
- Friends Research Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01096550
The ClinicalTrials.gov registry entry for NCT01096550 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 319 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 270-participant average among 9 other Drug Dependence trials with a reported enrollment target (18% higher). The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Drug Dependence appearing as the primary indexed condition, and to 2 interventions - of which Outpatient is the first listed.
NCT01096550 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01096550 about?
NCT01096550 is a clinical study titled "Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans". The purpose of this study is to compare the effectiveness of different levels of counseling (intensive outpatient versus standard outpatient) on treatment outcomes for African American adult patients receiving buprenorphine in 2 formerly "drug-free" programs.
What is the current status of trial NCT01096550?
This trial is currently completed. It is a NA study. The enrollment target is 319 participants. The study started on 2010-03. Estimated completion is 2011-10.
What conditions does trial NCT01096550 study?
This clinical trial studies the following conditions: Drug Dependence.
What interventions are being tested in trial NCT01096550?
The interventions under investigation include: Outpatient (BEHAVIORAL), Intensive Outpatient (BEHAVIORAL).
Who is sponsoring clinical trial NCT01096550?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01096550 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CB1R in Synthetic Psychoactive Cannabinoids
ACTIVE NOT RECRUITING · NA
-
Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
COMPLETED · NA
-
Innovative Digital Therapeutic for Smoking Cessation
COMPLETED · NA
-
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
COMPLETED · Phase 3
-
Drug Discrimination in Methadone-Maintained Humans Study 3
COMPLETED · Phase 1
-
The Effect of Fetal Gender on Maternal Substance Abuse Treatment
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.